There are many pharmacologic therapies that are being used or considered for treatment of
coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence …

Abstract Introduction An epidemic of Coronavirus Disease 2019 (COVID-19) began in
December 2019 in China leading to a Public Health Emergency of International Concern …

Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

Background Many studies on COVID-19 have reported diabetes to be associated with
severe disease and mortality, however, the data is conflicting. The objectives of this meta …

Background The purpose of this analysis is to provide evidence-based and consensus-
derived guidance for clinicians to improve individual diagnostic decision-making for …

Background Nurses represent the major proportion of frontline health care professionals
delivering 24/7 services to patients with an increased vulnerability towards COVID-19 …

Adults with autism spectrum disorder (ASD) are thought to be at disproportionate risk of
develo** mental health comorbidities, with anxiety and depression being considered most …

Objective Evidence-based characterization of the diagnostic and prognostic value of the
hematological and immunological markers related to the epidemic of Coronavirus Disease …

We present a new tool for meta‐analysis, Meta‐Essentials, which is free of charge and easy
to use. In this paper, we introduce the tool and compare its features to other tools for meta …

Background As an immune modulator, vitamin D has been implicated in the coronavirus
disease‐2019 (COVID‐19) outcome. We aim to systematically explore the association of …